01/18/2023 | Press release | Distributed by Public on 01/18/2023 10:09
The Respiratory Virus Hospitalization Surveillance Network (RESP-NET) comprises three platforms that conduct population-based surveillance for laboratory-confirmed hospitalizations associated with COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) among children and adults. While RESP-NET does not collect data on all hospitalizations caused by respiratory illnesses, it can describe hospitalizations caused by three viruses that account for a large proportion of these hospitalizations. Surveillance is conducted through a network of acute care hospitals in select counties in 13 states. The surveillance platforms for COVID-19, Influenza, and RSV (known as COVID-NET, FluSurv-NET, and RSV-NET, respectively) cover more than 29 million people and include an estimated 8-10% of the U.S. population.
The rates presented on the RESP-NET interactive dashboard can be used to follow trends and compare COVID-19, Influenza, and RSV-associated hospitalization rates in different demographic groups including by age, sex, and race and ethnicity, and across seasons. Surveillance for COVID-19, Influenza, and RSV in RESP-NET relies on clinical testing ordered by a healthcare provider. Hospitalization rates are unadjusted and do not account for undertesting, differing provider or facility testing practices, and diagnostic test sensitivity. The true burden of COVID-19, Influenza, and RSV-associated hospitalizations in the United States may be greater than what is shown by these numbers.
RESP-NET hospitalization data are preliminary and subject to change as more data become available. Rates for recent hospital admissions are subject to reporting delays that might increase around holidays or during periods of increased hospital utilization. As new data are received each week, previous rates are updated accordingly.
To see further hospitalization data on each respiratory virus, click on the link: